Protect Your Vision.
Preserve Your Independence.
Valeda is the first and only FDA-authorized treatment for dry age-related macular degeneration (AMD).
Valeda Light Delivery Therapy offers new hope for patients living with dry AMD by using light-based technology to preserve and restore vision.
Advanced AMD Treatment, Trusted Expertise
Experience the latest breakthrough in dry macular degeneration care. As one of the first 15 practices in the country to provide Valeda Light Delivery Therapy, we’re proud to bring this innovative treatment to our community.
Our mission is to improve each patient’s quality of life by preserving and enhancing vision. We are committed to delivering compassionate, personalized care and maintaining the highest standards of eye health throughout every stage of life.
How is Dry Macular Degeneration Treated?
Dry age-related macular degeneration has historically been managed through nutritional supplements (AREDS2 formula), lifestyle modifications like smoking cessation and UV protection, and regular monitoring to track its progression. While these options help slow the advancement of the condition, possibly preventing it from reaching more severe stages, they don’t address the underlying issues that cause vision loss.
The introduction of photobiomodulation therapy and the advanced Valeda Light Delivery System, represents a revolutionary breakthrough in dry AMD treatment. This FDA-authorized therapy uses precisely calibrated light wavelengths to stimulate cellular repair and support retinal health at the source of the problem. Unlike traditional management options, photobiomodulation offers the potential to not only slow progression but also actively preserve and potentially restore vision, providing new hope for patients with early to intermediate dry AMD.
Benefits of Valeda Photobiomodulation
Prevent Blindness due to Dry Macular Degeneration.
Photobiomodulation (PBM) is an emerging, non-invasive therapy for dry age-related macular degeneration (AMD). It uses specific wavelengths of light to stimulate cell activity, promote tissue repair, and support the health of retinal cells.
While research is still ongoing, PBM, including treatments like the LumiThera Valeda Light Delivery System, is showing promising results, particularly for those with early to intermediate stages of dry AMD.
Key Potential Benefits of PBM Therapy
Clinically Backed Technology
Improved Retinal Blood Flow
Supports Cellular Repair
Potential Vision Improvements
Compassionate Care from our Expert Retina Specialists
Our dedicated team provides advanced retinal care with a patient-first approach, ensuring you receive the highest level of expertise and support. From diagnosis to treatment, the team at Metrolina Eye Associates is committed to preserving and restoring your vision with personalized care tailored to your needs. Trust our specialists to guide you every step of the way.
Complex Retina Analysis & Second Opinions
Our comprehensive retinal evaluation uses advanced diagnostic technology to provide a thorough assessment and accurate diagnosis of complex retinal conditions. Advanced imaging systems, including optical coherence tomography (OCT), fundus photography, fluorescein angiography, and specialized visual field testing, allow us to examine retinal structures in detail.
These sophisticated tools can allow your eye doctor to detect subtle changes early and provide the precise measurements necessary for monitoring the progression of your condition and treatment response.
Retinal conditions can be complex, and patients often seek additional perspectives on their diagnosis and treatment options. Our experienced team welcomes second opinion consultations, offering patients the confidence that comes with expert review of their case. During your visit, we conduct comprehensive testing that may include dilated fundus exam, advanced retinal imaging, and specialized diagnostic procedures as needed.
Plans & Pricing
While Valeda Light Delivery Therapy is not currently covered by most insurance plans, we believe investing in your vision today can help prevent significant vision loss tomorrow. We’re pleased to accept CareCredit, North America’s leading patient healthcare financing program, which allows you to begin your Valeda treatment immediately and pay for it over time with monthly payments that fit comfortably into your budget.
CareCredit is a credit card exclusively designed for healthcare services and offers special financing options for procedures not commonly covered by insurance. With CareCredit’s flexible payment plans, you don’t have to delay this breakthrough treatment for your dry AMD.
Our team will help you explore financing options that make this innovative therapy accessible and affordable.
Who is a Candidate for Valeda Treatment?
Valeda Light Delivery Therapy is specifically designed for patients diagnosed with dry age-related macular degeneration in the early to intermediate stages. Ideal candidates include those who have been diagnosed with drusen (yellow deposits under the retina) and those experiencing gradual central vision changes. The treatment is particularly beneficial for patients seeking to preserve their current vision and maintain independence in daily activities like reading, driving, and recognizing faces. You may be an excellent candidate for Valeda if you have dry AMD and want a non-invasive treatment option that doesn’t require injections or surgery.
Our specialists will conduct a comprehensive evaluation to determine if your specific type and stage of macular degeneration would benefit from photobiomodulation therapy. Schedule a consultation to learn whether Valeda treatment can help preserve your vision and quality of life.